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Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease of unknown etiology. Genetic variation within
different major histocompatibility complex (MHC) loci contributes to the susceptibility to IPF. The effect of 70 kDa heat
shock proteins (HSP70) gene polymorphisms in the susceptibility to IPF is unknown. The aim of this study was to
explore the association between HSP70 polymorphisms and IPF susceptibility in the Mexican population.
Methods: Four HSP70 single nucleotide polymorphisms (SNPs) were evaluated using real time PCR assays in 168 IPF
patients and 205 controls: +2763 C>T of HSPA1L (rs2075800), +2437 of HSP HSPA1L A>G (rs2227956), +190 of HSPA1A
G>C (rs1043618) and +1267 of HSPA1B G>A (rs1061581).
Results: The analysis of the recessive model revealed a significant decrease in the frequency of the genotype
HSPA1B AA (rs1061581) in IPF patients (OR = 0.27, 95 % CI = 0.13–0.57, Pc = 0.0003) when compared to controls.
Using a multivariate logistic regression analysis in a codominant model the HSPA1B (rs1061581) GA and AA genotypes
were associated with a lower risk of IPF compared with GG (OR = 0.22, 95 % CI = 0.07–0.65; p = 0.006 and OR = 0.17,
95 % CI = 0.07–0.41; p = <0.001). Similarly, HSPA1L (rs2227956) AG genotype (OR = 0.34, 95 % CI = 0.12–0.99; p = 0.04)
and the dominant model AG + GG genotypes were also associated with a lower risk of IPF (OR = 0.24, 95 % CI = 0.08–0.67;
p = 0.007). In contrast, the HSPA1L (rs2075800) TT genotype was associated with susceptibility to IPF (OR = 2.52, 95 %
CI = 1.32–4.81; p = 0.005).
Conclusion: Our findings indicate that HSPA1B (rs1061581), HSPA1L (rs2227956) and HSPA1 (rs1043618) polymorphisms
are associated with a decreased risk of IPF.
Keywords: Idiopathic pulmonary fibrosis, Single nucleotide polymorphisms, Heat shock proteins of 70 kDa (HSP70), MHC
polymorphisms
Background
Idiopathic pulmonary fibrosis (IPF) is a progressive
and usually lethal disease of unknown etiology char-
acterized by alveolar epithelial cell activation, fibro-
blast/myofibroblasts proliferation and activation and
exaggerated accumulation of extracellular matrix (ECM)
in lung parenchyma [1]. A wide variety of genetic risk fac-
tors likely involved in susceptibility to develop IPF have
been described including common variants in MUC5B
[2], TERT, a component of telomerase [2, 3], Toll-
interacting protein (TOLLIP) [4], surfactant protein A and
B [5] and polymorphisms within the major histocompati-
bility complex (MHC) [6]. In this context, we have re-
ported that MHC class I chain-related gene A (MICA)
polymorphisms might also contribute to IPF susceptibility
in Mexicans [7]. These findings and the multifactorial na-
ture of IPF suggest that there may be other unidentified
genetic factors within the MHC region involved in IPF
susceptibility. HSP70 genes are coded within MHC class
III region and their products are involved in the binding
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and stabilization of nascent peptides for their correct fold-
ing to achieve appropriate conformations and in the re-
moval of misfolded and denaturized proteins [8–10].
Emerging evidence indicates that endoplasmic reticulum
(ER) stress and activation of the unfolded protein response
(UPR) may play a role in the pathogenesis of IPF [11]. Var-
iations in the sequence of HSP70 genes appear to affect
the expression or function of HSP70 proteins resulting in
altered stress tolerance mechanisms and contributing to
the susceptibility to different pathological conditions [12].
HSP70 gene variations are also associated with alterations
in oxidative stress [13–22]. There are three major genes of
the family of human HSP70 within the MHC class III re-
gion; these genes are HSP70-1 (HSPA1A, OMIM: 140550),
HSP70-2 (HSPA1B; OMIM: 603012) and HSP70-HOM
(HSP70A1L; OMIM: 140559) [23]. The products of the
first two genes encode a similar heat-inducible Hsp70 pro-
tein that differ only in two amino acids; whereas HSP70-
HOM encodes a non–heat-inducible protein that shares
high homology with the protein products of HSP70-1 and
HSP70-2 [8–10, 24]. Some report functional consequences
of the HSP70 SNPs, for example in the +190 C allele of
HSPA1A, located in the 5′ UTR region, provokes a reduc-
tion in the promoter activity and HSP70 protein expres-
sion than +190 G allele [25]. The polymorphisms
HSPA1B-179 C>T and HSPA1B 1267 A>G have been also
associated with differential production of HSPA1A and
HSPA1B mRNA [26]. Also, the HSP70-HOM +2437 A>G
(Met493Thr) polymorphism in the peptide-binding do-
main appears to affect the substrate specificity and
chaperone activity of this protein [12, 27].
The aim of the present study was to examine the pos-
sible association of HSP70 gene polymorphisms with the
susceptibility to IPF in the Mexican population.
Methods
Patients
One hundred sixty eight Mexican patients with diagnosis
of IPF were included in this study (103 males, 65 fe-
males, 64.5 ± 11.0 years old). Patients were recruited
from the Interstitial Lung Diseases Clinic of the Instituto
Nacional de Enfermedades Respiratorias “Ismael Cosio
Villegas”. Diagnosis of IPF was made with the currently
accepted international criteria [28].
Patients with known causes of interstitial lung disease
(i.e., collagen vascular disease, drug toxicity, environ-
mental exposure) were excluded.
As controls, we included 205 unrelated healthy volun-
teers (36 males, 169 females), with an average age of 47 ±
5.4 years. Control subjects included non-smokers and
smokers with normal lung function.
Patients and controls were individuals with the same
ethnic origin and with at least two generations born in
Mexico.
Written informed consent letter was obtained from all
patients and controls. The protocol was reviewed and
approved by the Scientific and Ethics Institutional Re-
view Board of the Instituto Nacional de Enfermedades
Respiratorias “Ismael Cosio Villegas”.
DNA isolation
Venous blood samples were collected in 5-ml EDTA
coated tubes from IPF patients and controls and DNA
was isolated using a BDtract genomic DNA isolation kit
(Maxim Biotech, San Francisco CA).
TaqMan 5' genotyping allelic discrimination assay
Variations of HSPA1L +2763 C>T (rs2075800), +2437
of HSPA1L A>G (rs2227956), + 190 of HSPA1A G>C
(rs1043618) and +1267 of HSPA1BG>A (rs1061581) were
genotyped by predesigned 5’ nuclease SNP genotyping
assays in accordance with the manufacturer protocol
(Applied Biosystems Foster City, CA). The selection of
these SNPs was based on the availability of previous stud-
ies regarding gene and allele frequencies in different
ethnic groups. The reagents included primers and allele-
specific probes 5’- labeled with VIC or FAM fluoro-
chromes to detect the alleles of HSPA1. Each reaction
contained 10 ng of genomic DNA, TaqMan Universal
PCR Master Mix (PE Applied Biosystems), 900 nM
primers, and 50 nM probes in 25 μl. The analyses were
performed using an ABI Prism Step One Real time PCR
System (Applied Biosystems Foster City, CA). Thermal
cycling conditions were 2 min at 50 °C, 10 min at 95 °C
and 40 cycles each of 95 °C for 15 s and 50 °C for 1 min.
Statistical analysis
Hardy–Weinberg equilibrium (HWE) was tested for all
genotypic combinations of each variant using the Haplo-
view software (Version 4.2) [29]. The allelic and geno-
typic frequencies were determined by direct counting in
patients and controls. Differences in allele, genotype and
haplotype frequencies were evaluated by the Pearson
Chi-square test that combined the 2 × 2 contingency ta-
bles in IPF patients and control group using the EPIINFO
statistical program (Version 6.04b). Corrected P (Pc)
values, odds ratio (OR) with 95 % confidence interval (CI)
were also estimated using EPIINFO. Statistical significance
of associations with minor allele positivity (dominant
model) or minor allele homozygosis (recessive model) was
assessed by OR and their 95 % CI were obtained. In these
models, the wild-type homozygous group was the refer-
ence group for comparisons [21].
For genotypes the value "p" of hypothesis testing be-
tween 4 polymorphisms under the 3 different models of
inheritance and the presence or absence of FPI was ad-
justed. The test used was the Bonferroni correction and
the calculation was carried out as follows: the level
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alpha/number of comparisons, the number of compari-
sons was determined by the number of SNPs (four)
multiplied by the number of models of inheritance
(three) between the alpha value that was 0.05 and the re-
sult was 0.004. This indicates that the values of p <0.004
can be considered statistically significant. For the alleles,
the number of comparisons was determined by the
number of alleles (four), between the alpha value (0.05);
the result was 0.0125 and this indicates that any values
of p <0.0125 can be considered statistically significant.
We decided to use genotypes as the primary comparison
due to the interest of establishing the possible associ-
ation from models of Mendelian inheritance: dominance,
co-dominant and recessive; furthermore, this approach
gives more comprehensive information these polymor-
phisms’ role in this disease. The hypothesis was built
under the dominant pattern of inheritance; the calcula-
tion power for this study was 0.885, this was calculated
in the Power and Sample Size software [30]. To adjust
the estimates and determine if these protection associa-
tions are independent, we performed a multivariate lo-
gistic regression analysis for four SNPs of HSP70 and
their association with the IPF for three models of genetic
inheritance.
Results
The allele and frequencies of HSP70 gene SNPs are
shown in Table 1. A decreased frequency of the G allele
of the SNP rs2227956 of HSPA1L gene was observed in
IPF patients when compared to controls (OR = 0.27,
95 % CI = 0.10–0.75, Pc = 0.01). The genotype frequen-
cies and the ORs for the codominant, dominant and re-
cessive models are also shown in Table 1. A significant
decrease in the frequency of the heterozygous AG geno-
type of the SNP rs2227956 of HSPA1L gene (OR = 0.26,
95 % CI = 0.09–0.72, Pc = 0.01,) and in the frequency of
the homozygous AA genotype of the SNP rs1061581 of
the HSPA1B gene was also found in the IPF group (OR
= 0.30, 95 % CI = 0.13–0.57, Pc = 0.001) when compared
to the control group. These associations were observed
in co-dominant and dominant models for genotype AG
of HSPA1L (rs2227956) and co-dominant and recessive
model for genotype AA of HSPA1B (rs1061581) (Table 1).
To adjust the estimates and determine if these genetic as-
sociations with IPF are independent, we performed a
multivariate logistic regression analysis of the four SNPs
of HSP70 and their association with the disease for three
models of genetic inheritance (Table 2). The pattern ob-
served in codominant HSPA1B (rs1061581) GA genotype
was associated with a lower risk, compared with GG
(OR = 0.22, 95 % CI = 0.07–0.65; p = 0.006), whereas
the comparison AA vs GG displayed a stronger
protective association with IPF (OR = 0.17, 95 % CI = 0.07–
0.41; p = <0.001). In contrast, HSPA1L (rs2075800) TT
genotype confers an increased risk for the development of
IPF (OR = 2.52, 95 % CI = 1.32–4.81; p = 0.005). In the
dominant model analysis we found that the genotypes
AG+GG of HSPA1 (rs2227956) (OR = 0.24, 95 %
CI = 0.089–0.679; p = 0.007) as well as the combination of
genotypes GC +CC (OR= 0.639, 95 % CI = 0.41–0.97;
p = 0.039) of HSPA1 (rs1043618) confer protection to IPF.
In the recessive model analysis we found that the AA
genotype of HSPA1B (rs1061581) seems equally protective
(OR = 0.68, 95 % CI = 0.07–0.03; p = <0.001), whereas the
TT genotype confers a risk for IPF development
(OR = 2.70, 95 % CI = 1.46–4.98; p = 0.001).
Finally, we also performed a haplotype analysis (Table 3)
and we found 10 haplotypes [HSPA1A- HSPA1B-
HSPA1L] in both studied groups. No significant differ-
ences in the distribution of haplotypes between IPF
patients and healthy controls were detected. To calculate
linkage disequilibrium in the control group the Hap-
loview 4.2 program was used [29]. In Fig. 1, we show
the plot of the linkage disequilibrium HSPA1B
(rs1061581) with HSP1AL (rs2075800) and HSPA1B
(rs1061581) with HSPA1A (rs1043618).
Discussion
Hsp70s, together with their Hsp40 co-chaperones, are
the most prominent chaperone families that participate
in chaperone-assisted proteosomal degradation of mis-
folded proteins [31]. Previously published functional
studies have highlighted the importance of HSP70 to at-
tenuate the abnormal lung remodelling after injury in
experimental models [32, 33]. Accordingly, it has been
shown that upregulation of HSP70 significantly decreases
the inflammatory and fibrotic response in bleomycin-
induced pulmonary damage, blocking the production of
TGF-β1 [33]. Likewise, there is evidence indicating that
gefitinib-induced exacerbation of bleomycin-induced lung
fibrosis is mediated by suppression of pulmonary ex-
pression of HSP70 [34]. However, studies in human
IPF are scarce. Intriguingly, it was found that a sub-
group of IPF patients has significantly greater extent
of anti-HSP70 humoral and cellular autoreactivities com-
pared with healthy controls. Moreover, abnormal anti-
HSP70 humoral autoimmunity was associated to poor
outcome. Whether the development of this autoreactivity
is related to some HSP70 polymorphisms is unknown
[35]. Interestingly, the autoimmune-associated HLA-B8-
DR3 haplotypes seems to include the HSPA1B 1267A/G
polymorphism [36]. Likewise, it has been reported in the
Chinese population that the A allele is more predominant
in patients with enterocutaneous fistulas than in healthy
controls [37]. In this study, we determined variants of
HSP70 genes in IPF patients and healthy controls from
Mexican ancestry. The most striking findings confirmed
by a multivariate analysis were that the GA and AA
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Table 1 HSPA1L, HSPA1A and HSPA1B genotype and allele frequencies in IPF patients and healthy controls
IPF n = 168 Control n = 205
Models Allele/Genotypes n f n f OR Pc 95 % C.I.
HSPA1L (C/T rs2075800)
C 181 0.79 230 0.56 1
T 155 0.21 180 0.44 1.09 0.54 0.81–1.46
C CC 53 0.31 59 0.28 1 – –
CT 75 0.44 112 0.54 0.74 –
TT 40 0.23 34 0.16 1.30 0.10 0.72–2.35
D CC 53 0.31 59 0.28 1 – –
CT + TT 115 0.68 146 0.71 0.87 0.56 0.56–1.36
R CC + CT 128 0.76 171 0.83 1 – –
TT 40 0.23 34 0.16 1.57 0.08 0.94–2.62
HSPA1L (A/G rs2227956)
A 331 0.99 389 0.95 1 – –
G 5 0.01 21 0.05 0.27 0.01 0.10–0.75
C AA 163 0.97 184 0.89 1 – –
AG 5 0.02 21 0.10 0.26 0.01 0.09–0.72
GG 0 0.00 0 0.00 – – –
D AA 163 0.97 184 0.89 1 – –
AG + GG 5 0.02 21 0.10 0.26 0.01 0.09–0.72
R AA + AG 168 1.00 205 1.00 1 – –
GG 0 0.00 0 0.00 – – –
HSPA1A (G/C rs1043618)
G 261 0.77 295 0.72 1 – –
C 75 0.22 115 0.28 0.73 0.07 0.52–1.03
C GG 100 0.59 102 0.49 1 – –
GC 61 0.36 91 0.44 0.68 –
CC 7 0.04 12 0.05 0.59 0.16 0.22–1.57
D GG 100 0.59 102 0.49 1 – –
GC + CC 68 0.40 103 0.50 0.68 0.07 0.45–1.03
R GG + GC 161 0.95 193 0.94 1 – –
CC 7 0.04 12 0.05 0.69 0.46 0.26–1.81
HSPA1B (G/A rs1061581)
G 199 0.56 215 0.52 1 – –
A 137 0.44 195 0.48 1.3 0.06 0.98–1.76
C GG 41 0.24 48 0.23 1 – –
GA 117 0.69 119 0.58 1.15 – –
AA 10 0.05 38 0.18 0.30 0.001 0.13–0.69
D GG 41 0.24 48 0.23 1 – –
GA + AA 127 0.75 157 0.76 0.94 0.82 0.58–1.52
R GG + AG 158 0.94 167 0.81 1 – –
AA 10 0.05 38 0.18 0.27 0.0003 0.13–0.57
C codominant, D dominant, R recessive, Pc p value corrected, IPF idiopathic pulmonary fibrosis, OR odds ratio, I.C. confidence interval. Significant associations are
highlighted with bold type
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genotypes of the HSPA1B (rs1061581) polymorphism were
associated with a lower risk of IPF. Also, AG genotype
and the AG+GG genotypes (in a dominant model) of the
SNP HSPA1L (rs2227956) were also associated with a
lower risk to develop IPF. On the other hand, the HSPA1L
(rs2075800) TT genotype was significantly associated with
susceptibility to IPF.
The polymorphism rs2227956 is located in the coding
region of the HSPA1L gene and leads to an amino acid
change at position 493 from a non-polar hydrophobic
Met to a polar neutral Thr. Amino acid 493 is present in
the 18 kDa peptide-binding domain on the beta sheet
that forms the floor of the peptide binding groove [38].
The HSPA1L polymorphic G allele translates to a Met
residue, an hydrophilic amino acid that may affect the
interaction of the HSP70 with hydrophobic proteins and
consequently impairs its ability to assemble and trans-
port proteins within cells [38, 39]. Intriguingly, a recent
meta-analysis study indicated that individuals with
HSPA1B AG/GG genotype, which seem to protect from
IPF, have an increased risk of cancer [40]. Previous stud-
ies have highlighted the functional consequences of dif-
ferent HSP-70 gene polymorphisms. The polymorphisms
Table 2 Analysis of multivariate logistic regression of four SNPs
of HSP70 and its association with the IPF for three genetic
inheritance models
B df p OR 95 % C. I.
Codominant model
HSPA1 rs1043618
GG Vs GC −0.72 1 0.16 0.48 0.17–1.36
GG Vs CC −0.28 1 0.59 0.75 0.26–2.12
HSPA1B rs1061581
GG Vs GA −1.50 1 0.006 0.22 0.07–0.65
GG Vs AA −1.73 1 <0.001 0.17 0.07–0.41
HSPA1L rs2227956
AA Vs AG −1.06 1 0.049 0.34 0.12–0.99
HSPA1L rs2075800
CC Vs CT 0.45 1 0.29 1.58 0.67–3.71
CC Vs TT 0.92 1 0.005 2.52 1.32–4.81
Dominant model
HSPA1L rs2227956
AA Vs AG + GG −1.40 1 0.007 0.24 0.08–0.67
HSPA1 rs1043618
GG Vs GC + CC −0.44 1 0.039 0.63 0.41–0.97
HSPA1B rs1061581
GG Vs GA + AA 0.17 1 0.63 1.18 0.59–2.39
HSPA1 rs2075800
CC Vs CT + TT −0.36 1 0.27 0.69 0.36–1.33
Reccesive model
HSPA1 rs1043618
GG + GC Vs CC −0.35 1 0.47 0.70 0.26–1.85
HSPA1B rs1061581
GG + AG Vs AA −1.78 1 <0.001 0.16 0.074–0.38
HSPA1L rs2075800
CC + CT Vs TT 0.99 1 0.001 2.70 1.46–4.98
p p value, OR odds ratio, I.C. confidence interval. Significant associations are
highlighted with bold type












IPF idiopathic pulmonary fibrosis
Fig. 1 Linkage disequilibrium plot of SNPs in HSP70 HOM
(rs2075800 and rs2227956), HSPA1A (rs1043618) and HSPA1B
(rs1061581), estimated as D´ using Haploview 4.2. The plot was
built with data of the control group
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+190 C of HSPA1A, HSPA1B-179 C>T and HSPA1B
1267 A>G have been linked with significant alterations
in the mRNA and protein expression [25, 26]. Also an
important functional effect at protein level of the poly-
morphism HSP70-HOM +2437 A>G (Met493Thr), af-
fecting the substrate specificity and chaperone activity of
HSP-70 HOM, has been described [12, 27]. The possible
mechanisms of HSP70 gene-disease associations in IPF
are unclear. In this context, strong evidence has revealed
the accumulation of unfolded and misfolded proteins
with severe endoplasmic reticulum (ER) stress in alveo-
lar epithelial cells lining areas of fibrosis [41]. It is pos-
sible that the functional effect of the HSPA1B 1267 A>G
polymorphism in the differential expression of HSPA1B
mRNA [26] might influence the protein expression of
pro-fibrotic proteins associated to the pathogenesis of
IPF. Moreover, it has been shown that the same cells
also display activation of pro-apoptotic pathways [42]. In
addition, ER stress may contribute to the pathogenesis
of IPF through the induction of epithelial to mesenchy-
mal transition, which may play a role in the expansion
of the fibroblast population. Consequently, a transient
increase in the expression of heat shock proteins is crit-
ical to prevent alveolar epithelial cell death and the shift
of epithelial cells to a mesenchymal phenotype. In this
perspective, an age-dependent decrease in the ability of
different cell types to synthesize HSP70 has been ob-
served, and moreover, some gene variants seem to con-
tribute to this decrease [43].
In our study, the combination of the two genotypes as-
sociated with protection was only found in healthy con-
trols and not in IPF patients (p = 0.005). In comparison
with former data of associated functional polymorphisms
[12, 18, 26, 27, 44], it seems that there is no direct rela-
tionship among them and those reported herein, since
these previous studies show that HSP70 protects from fi-
brosis development. Strikingly, our results point out that
genotypes involved in the decreased induction of these
proteins might provide protection against IPF. Moreover,
the association between these polymorphisms and IPF
protection may be due to LD with other adjacent genes.
In this regard, an LD has been reported between the
TNF locus and HSPA1B [45].
To determine whether the associations described in
the three models of inheritance are independent of LD
between the SNPs analyzed, a multivariate analysis was
performed. As a result we confirmed that these associa-
tions are independent of LD. The differences in the associ-
ation with IPF between the three models of inheritance
may indicate that the segregation of one or two genotypes
of protection or risk act independently, either as protect-
ive or risk IPF factors, respectively. The present study has
some limitations and replications in other populations are
needed to verify these findings, since polymorphisms
suggesting fibrosis protection are relatively rare. Not-
withstanding, we were able to confirm HSP70 polymor-
phisms association with the protection to IPF with a
statistical power greater that 80 %, even with the strin-
gently defined number of IPF cases studied. Another limi-
tation was the imbalanced distribution of males and
females among IPF and control group. In this regard, a
possible bias of the genetic association analysis may be
due to the gender disparities. However, in previous
genetic-association studies of MHC genes, no marked dif-
ferences in the MHC genes frequencies have been de-
tected between males and females from Mexican ancestry
[6]. Furthermore, it is well know that IPF is more frequent
in Mexican males and due to the age of onset of the dis-
ease, it is more frequent to have healthy females than
males.
Finally, we compared the frequencies of HSP70 SNPs
genotypes between Mexicans and other ethnic groups
(Additional file 1: Table S1). In this analysis we found
that the homozygous TT genotype of the polymorphism
rs2075800 of the HSPA1L gene is the most common
genotype, whereas CC genotype is the least frequent
genotype in Italian Caucasians [46] and Croatian [47]
subjects. We also observed that in Asian populations in-
cluding Chinese [48] and Taiwanese [49] as well as in
Mexicans, the CC genotype is frequent and the genotype
TT is uncommon. The genotypic frequencies HSPA1L
with rs2227956 are similar in all population groups.
Likewise, for the HSPA1A rs1043618 gene, the GG
genotype is more frequent in Chinese, Taiwanese, Pol-
ish [50, 51] and Mexicans; in contrast, the most com-
mon in Italians is heterozygous CG, and the least
frequent in all populations, is the homozygous CC.
Conclusions
In summary, the present study suggests that genetic
variation in the HSPA1L and HSPA1B genes may influ-
ence the susceptibility of developing IPF in our popula-
tion. Additional investigations with other populations
are needed to confirm the significance of our findings
and the functionality properties of these polymorphisms.
Additional file
Additional file 1: Table S1. Genotype frequencies of HSPA1L, HSPA1A
and HSPA1B in different populations. (DOC 55 kb)
Abbreviations
IPF: Idiopathic pulmonary fibrosis; MHC: Major histocompatibility complex;
HSP70: Heat shock proteins; SNP: Single nucleotide polymorphism;
ECM: Extracellular matrix; TOLLIP: Toll-interacting protein; MICA: MHC class I
chain-related gene A; ER: Endoplasmic reticulum; UPR: Unfolded protein
response; DNA: Desoxiribonucleic acid; HWE: Hardy–Weinberg equilibrium;
OR: Odds ratio; TGF-β1: Transforming growth factor beta 1; HLA: Human
leukocyte antigen; LPS: Lipopolysaccharide.
Aquino-Gálvez et al. BMC Pulmonary Medicine  (2015) 15:129 Page 6 of 8
Competing interests
The authors do not have any non-financial competing interests to declare.
Authors’ contributions
AAG, GGA, JZ, MPR, BSC, AP and MS conceived and designed the study, data
analysis and wrote the manuscript. AAG, MPR, OPP, MNR, IPR, MC, VR, FU
carried out the genetic analysis and sample processing and data analysis. All
authors read and approved the final manuscript.
Acknowledgements
This study was supported by research funds from the Instituto Nacional de
Enfermedades Respiratorias Ismael Cosío Villegas.
Author details
1Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”
Tlalpan 4502, Col. Sección XVI, 14080 Mexico, México. 2Hospital General de
México, Universidad Nacional Autónoma de México, Laboratorio de
Inmunología, Mexico, Mexico. 3Unidad de Investigación Médica en
Inmunología, CMN S-XXI Instituto Mexicano del Seguro Social, Mexico,
Mexico.
Received: 24 June 2015 Accepted: 14 October 2015
References
1. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and
evolving hypotheses about its pathogenesis and implications for therapy.
Ann Intern Med. 2001;134:136–51.
2. Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, Steele MP, et al.
Genome-wide association study identifies multiple susceptibility loci for
pulmonary fibrosis. Nat Genet. 2013;45:613–20.
3. Mushiroda T, Wattanapokayakit S, Takahashi A, Nukiwa T, Kudoh S, Ogura T,
et al. A genome-wide association study identifies an association of a
common variant in TERT with susceptibility to idiopathic pulmonary fibrosis.
J Med Genet. 2008;45:654–56.
4. Noth I, Zhang Y, Ma SF, Flores C, Barber M, Huang Y, et al. Genetic variants
associated with idiopathic pulmonary fibrosis susceptibility and mortality: a
genome-wide association study. Lancet Respir Med. 2013;1:309–17.
5. Selman M, Lin HM, Montaño M, Jenkins AL, Estrada A, Lin Z, et al. Surfactant
protein A and B genetic variants predispose to idiopathic pulmonary
fibrosis. Hum Genet. 2003;113:542–50.
6. Falfán-Valencia R, Camarena A, Juárez A, Becerril C, Montaño M, Cisneros J,
et al. Major histocompatibility complex and alveolar epithelial apoptosis in
idiopathic pulmonary fibrosis. Hum Genet. 2005;118:235–44.
7. Aquino-Galvez A, Pérez-Rodríguez M, Camarena A, Falfan-Valencia R, Ruiz V,
Montaño M, et al. MICA polymorphisms and decreased expression of the
MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis
susceptibility. Hum Genet. 2009;125:639–48.
8. Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA, et al.
Guidelines for the nomenclature of the human heat shock proteins. Cell
Stress Chaperones. 2009;14:105–11.
9. Zhou F, Wang F, Li F, Yuan J, Zeng H, Wei Q, et al. Association of hsp70-2
and hsp-hom gene polymorphisms with risk of acute high-altitude illness in
a Chinese population. Cell Stress Chaperones. 2005;10:349.
10. Wang Y, Zhou F, Wu Y, Xu D, Li W, Liang S. The relationship between three
heat shock protein 70 gene polymorphisms and susceptibility to lung
cancer. Clin Chem Lab Med. 2010;48:1657–63.
11. Tanjore H, Blackwell TS, Lawson WE. Emerging evidence for endoplasmic
reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis. Am J
Physiol Lung Cell Mol Physiol. 2012;302:L721–9.
12. Milner C, Campbell RD. Polymorphic analysis of the three MHC-linked
HSP70 genes. Immunogenetics. 1992;36:357–62.
13. Ishihara M, Ohno S, Ishida T, Mizuki N, Ando H, Naruse T, et al. Genetic
polymorphisms of the TNFB and HSP70 genes located in the human major
histocompatibility complex in sarcoidosis. Tissue Antigens. 1995;46:59–62.
14. Favatier F, Bornman L, Hightower LE, Günther E, Polla BS. Variation in hsp
gene expression and Hsp polymorphism: do they contribute to differential
disease susceptibility and stress tolerance. Cell Stress Chaperones.
1997;2:141–55.
15. Vargas-Alarcón G, Londoño JD, Hernández-Pacheco G, Gamboa R, Castillo E,
Pacheco-Tena C, et al. Heat shock protein 70 gene polymorphisms in
Mexican patients with spondyloarthropathies. Ann Rheum Dis.
2002;61:48–51.
16. Li JX, Tang BP, Sun HP, Feng M, Cheng ZH, Niu WQ. Interacting contribution
of the five polymorphisms in three genes of Hsp70 family to essential
hypertension in Uygur ethnicity. Cell Stress Chaperones. 2009;14:355–62.
17. Mir KA, Pugazhendhi S, Paul MJ, Nair A, Ramakrishna BS. Heat-shock protein
70 gene polymorphism is associated with the severity of diabetic foot ulcer
and the outcome of surgical treatment. Br J Surg. 2009;96:1205–09.
18. He M, Guo H, Yang X, Zhang X, Zhou L, Cheng L, et al. Functional SNPs in
HSPA1A gene predict risk of coronary heart disease. PLoS One.
2009;4, e4851.
19. Ayub H, Khan MI, Micheal S, Akhtar F, Ajmal M, Shafique S, et al. Association
of eNOS and HSP70 gene polymorphisms with glaucoma in Pakistani
cohorts. Mol Vis. 2010;16:18–25.
20. Zhang H, Jin T, Zhang G, Chen L, Zou W, Li QQ, et al. Polymorphisms in
heat-shock protein 70 genes are associated with coal workers ’
pneumoconiosis in Southwestern China. In Vivo. 2011;258:251–57.
21. Ucisik-Akkaya E, Davis CF, Gorodezky C, Alaez C, Dorak MT. HLA complex-linked
heat shock protein genes and childhood acute lymphoblastic leukemia
susceptibility. Cell Stress Chaperones. 2010;15:475–85.
22. Partida-Rodríguez O, Torres J, Flores-Luna L, Camorlinga M, Nieves-Ramírez M,
Lazcano E, et al. Polymorphisms in TNF and HSP-70 show a significant
association with gastric cancer and duodenal ulcer. Int J Cancer.
2010;126:1861–68.
23. Milner CM, Campbell RD. Structure and expression of the three MHC-linked
HSP70 genes. Immunogenetics. 1990;32(4):242–51.
24. Fourie AM, Peterson PA, Yang Y. Characterization and regulation of the
major histocompatibility complex–encoded proteins Hsp70-Hom and
Hsp70-1/2. Cell Stress Chaperones. 2001;6(3):282.
25. He M, Guo H, Yang X, Zhang X, Zhou L, Cheng L, et al. Functional SNP in
HSP1A gene predict risk of coronary heart disease. Plos One.
2009;4(3):e4851.
26. Temple SE, Cheong KY, Ardlie KG, Sayer D, Waterer GW. The septic shock
associated HSPA1B1267 polymorphism influences production of HSPA1A and
HSPA1B. Intensive Care Med. 2004;30(9):1761–7.
27. Wei Y, Wang W, He Y, Jiang L, Hou Z, Gao X, et al. Interaction between
hypertension and HSP70 variants increase the risk of cerebral ischemia in
Chinese Han population: an association study. Gene. 2013;513(2):239–43.
28. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official
ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based
guidelines for diagnosis and management. Am J Respir Crit Care Med.
2011;183:788–824.
29. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of
LD and haplotype maps. Bioinformatics. 2005;21:263–65.
30. Dupont WD, Plummer WD. Power and sample size calculations for studies
involving linear regression. Control Clin Trials. 1998;19:589–601.
31. Shiber A, Ravid T. Chaperoning proteins for destruction: diverse roles of
Hsp70 chaperones and their co-chaperones in targeting misfolded proteins
to the proteasome. Biomolecules. 2014;4:704–24.
32. Hagiwara S, Iwasaka H, Matsumoto S, Noguchi T, Yoshioka H. Association
between heat stress protein 70 induction and decreased pulmonary fibrosis
in an animal model of acute lung injury. Lung. 2007;185:287–93.
33. Tanaka K, Tanaka Y, Namba T, Azuma A, Mizushima T. Heat shock protein 70
protects against bleomycin-induced pulmonary fibrosis in mice. Biochem
Pharmacol. 2010;80:920–31.
34. Namba T, Tanaka K, Hoshino T, Azuma A, Mizushima T. Suppression of
expression of heat shock protein 70 by gefitinib and its contribution to
pulmonary fibrosis. PLoS One. 2011;6, e27296.
35. Kahloon RA, Xue J, Bhargava A, Csizmadia E, Otterbein L, Kass DJ, et al.
Patients with idiopathic pulmonary fibrosis with antibodies to heat shock
protein 70 have poor prognoses. Am J Respir Crit Care Med. 2013;187:768–75.
36. Kaur G, Kumar N, Szilagyi A, Blasko B, Fust G, Rajczy K, et al. Autoimmune-
associated HLA-B8-DR3 haplotypes in Asian Indians are unique in C4
complement gene copy numbers and HSP-2 1267A/G. Hum Immunol.
2008;69:580–87.
37. Chen J, Ren JA, Han G, Gu GS, Wang GF, Wu XW, et al. Polymorphism of
heat shock protein 70–2 and enterocutaneous fistula in Chinese population.
World J Gastroenterol. 2014;20:12559–65.
38. Pociot F, Ronningen KS, Nerup J. Polymorphic analysis of the human MHC-Linked
Heat Shock Protein 70 (HSP70-2) and HSP70-Hom Genes in Insulin-Dependent
Diabetes Mellitus (IDDM). Scand J Immunol. 1993;38:491–95.
Aquino-Gálvez et al. BMC Pulmonary Medicine  (2015) 15:129 Page 7 of 8
39. Ross OA, Curran MD, Crum KA, Rea IM, Barnett YA, Middleton D. Increased
frequency of the 2437 T allele of the heat shock protein 70-Hom gene in an
aged Irish population. Exp Gerontol. 2003;38:561–65.
40. He L, Deng T, Luo H. Heat shock protein 70 gene polymorphisms and
cancer risk: a meta-analysis. Scientific World Journal. 2014;2014:540309.
41. Lawson WE, Crossno PF, Polosukhin VV, Roldan J, Cheng DS, Lane KB, et al.
Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF:
association with altered surfactant protein processing and herpesvirus
infection. Am J Physiol Lung Cell Mol Physiol. 2008;294:L1119–26.
42. Korfei M, Ruppert C, Mahavadi P, Henneke I, Markart P, Koch M, et al.
Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic
pulmonary fibrosis. Am J Respir Crit Care Med. 2008;178:838–46.
43. Singh R, Kølvraa S, Bross P, Jensen UB, Gregersen N, Tan Q, et al. Reduced
heat shock response in human mononuclear cells during aging and its
association with polymorphisms in HSP70 genes. Cell Stress Chaperones.
2006;11:208.
44. Jenkins SC, March RE, Campbell RD, Milner CM. A novel variant of the
MHC-linked hsp70, hsp70-hom, is associated with rheumatoid arthritis.
Tissue Antigens. 2000;56(1):38–44.
45. Schroeder S, Reck M, Hoeft A, Stuber F. Analysis of two human leukocyte
antigen-linked polymorphic heat shock protein 70 genes in patients with
severe sepsis. Crit Care Med. 1999;27:1265–70.
46. Maggioli E, Boiocchi C, Zorzetto M, Mannarino S, Bossi G, Cuccia M. HLA
class III genes involvement in Kawasaki disease: a case–control study in
Caucasian population. Int J Immunogenet. 2014;41:44–53.
47. Matokanović M, Rumora L, Popović-Grle S, Čepelak I, Čulić O, Barišić K.
Association of hsp70-2 (+1267A/G), hsp70-hom (+2437 T/C), HMOX-1
(number of GT repeats) and TNF-alpha (+489G/A) polymorphisms with
COPD in Croatian population. Clin Biochem. 2012;45:770–74.
48. Guo H, Deng Q, Wu C, Hu L, Wei S, Xu P, et al. Variations in HSPA1B at
6p21.3 are associated with lung cancer risk and prognosis in Chinese
populations. Cancer Res. 2011;71:7576–86.
49. Chien CY, Chang NC, Tai SY, Wang LF, Wu MT, Ho KY. Heat shock protein
70 gene polymorphisms in sudden sensorineural hearing loss. Audiol
Neurootol. 2012;17:381–85.
50. Kowalczyk M, Owczarek A, Suchanek R, Paul-Samojedny M, Fila-Danilow A,
Borkowska P, et al. Heat shock protein 70 gene polymorphisms are
associated with paranoid schizophrenia in the Polish population. Cell Stress
Chaperones. 2014;19:205–15.
51. Zhang Y, Gong J, Zhang L, Xue D, Liu H, Liu P. Genetic polymorphisms of
HSP70 in age-related cataract. Cell Stress Chaperones. 2013;18:703–9.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Aquino-Gálvez et al. BMC Pulmonary Medicine  (2015) 15:129 Page 8 of 8
